{{Rsnum
|rsid=1870049
|Gene=CYP19A1
|Chromosome=15
|position=51333026
|Orientation=plus
|GMAF=0.2415
|Gene_s=CYP19A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 26.5 | 71.7
| HCB | 5.8 | 36.5 | 57.7
| JPT | 4.4 | 31.0 | 64.6
| YRI | 23.1 | 49.0 | 27.9
| ASW | 17.5 | 49.1 | 33.3
| CHB | 5.8 | 36.5 | 57.7
| CHD | 2.8 | 32.1 | 65.1
| GIH | 7.9 | 24.8 | 67.3
| LWK | 23.6 | 52.7 | 23.6
| MEX | 0.0 | 24.1 | 75.9
| MKK | 14.1 | 49.4 | 36.5
| TSI | 4.0 | 25.7 | 70.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22638611
|Title=Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy
}}

{{PMID Auto
|PMID=16733710
|Title=Association analyses of CYP19 gene polymorphisms with height variation in a large sample of Caucasian nuclear families.
|OA=1
}}

{{PMID Auto
|PMID=16782804
|Title=Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.
|OA=1
}}

{{PMID Auto
|PMID=18274619
|Title=Association study of aromatase gene (CYP19A1) in essential hypertension.
|OA=1
}}

{{PMID Auto
|PMID=18636124
|Title=Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=19064562
|Title=Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.
|OA=1
}}

{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}